Back to Search
RENE HINKLE, M.D.
M.D.
Obstetrics & Gynecology Physician
NPI: 1083741128IndividualAccepts Medicare
Specialties, Licenses & Credentials
Obstetrics & Gynecology PhysicianPrimary
Obstetrics & Gynecology
Code: 207V00000X
6186A(WY)
CMS Specialties
PrimaryOBSTETRICS/GYNECOLOGY
Education
OTHER
Class of 1991
Research & Publications (20)
Systemic administration of diarylpropionitrile (DPN) or phytoestrogens does not affect anxiety-related behaviors in gonadally intact male rats.
PMID 19071129·Horm Behav·2009
7-preclinical
West Nickel Mines School shooting: how a rural MCI was successfully managed.
PMID 18482651·JEMS·2008
8-other
Maximal force is unaffected by emphysema-induced atrophy in extensor digitorium longus.
PMID 18314399·Respir Physiol Neurobiol·2008
7-preclinical
Corticortophin releasing factor 2 receptor agonist treatment significantly slows disease progression in mdx mice.
PMID 17626629·BMC Med·2007
7-preclinical
Modifications of the human urocortin 2 peptide that improve pharmacological properties.
PMID 16476507·Peptides·2006
7-preclinical
BiBr3-initiated tandem addition/silyl-Prins reactions to 2,6-disubstituted dihydropyrans.
PMID 16930067·J Org Chem·2006
8-other
ICAT-MS-MS time course analysis of atrophying mouse skeletal muscle cytosolic subproteome.
PMID 16880987·Mol Biosyst·2005
7-preclinical
Phosphodiesterase 4 inhibition reduces skeletal muscle atrophy.
PMID 16116651·Muscle Nerve·2005
4-observational
Activation of the vasoactive intestinal peptide 2 receptor modulates normal and atrophying skeletal muscle mass and force.
PMID 15649881·J Appl Physiol (1985)·2005
4-observational
Discovery of corticotropin releasing factor 2 receptor selective sauvagine analogues for treatment of skeletal muscle atrophy.
PMID 15634020·J Med Chem·2005
7-preclinical
Corticotropin releasing factor 2 receptor agonists reduce the denervation-induced loss of rat skeletal muscle mass and force and increase non-atrophying skeletal muscle mass and force.
PMID 15711884·J Muscle Res Cell Motil·2004
4-observational
Corticotropin-releasing factor 2 receptor localization in skeletal muscle.
PMID 15208363·J Histochem Cytochem·2004
7-preclinical
Urocortin II treatment reduces skeletal muscle mass and function loss during atrophy and increases nonatrophying skeletal muscle mass and function.
PMID 12960070·Endocrinology·2003
7-preclinical
Stereoselective construction of cyclic ethers using a tandem two-component etherification: elucidation of the role of bismuth tribromide.
PMID 13129322·J Am Chem Soc·2003
8-other
Activation of the CRF 2 receptor modulates skeletal muscle mass under physiological and pathological conditions.
PMID 12959937·Am J Physiol Endocrinol Metab·2003
4-observational
Continuous low-level heat wrap therapy provides more efficacy than Ibuprofen and acetaminophen for acute low back pain.
PMID 12004166·Spine (Phila Pa 1976)·2002
3-trial
Skeletal muscle hypertrophy and anti-atrophy effects of clenbuterol are mediated by the beta2-adrenergic receptor.
PMID 11994968·Muscle Nerve·2002
7-preclinical
Structural and electronic characteristics of thienyl(aryl)iodonium triflates.
PMID 11975530·J Org Chem·2002
8-other
(Z)-2-Methylbuten-1-yl(aryl)iodonium trifluoromethanesulfonates containing electron-withdrawing groups on the aryl moiety.
PMID 11828128·Acta Crystallogr C·2002
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 3 locations total
- Address
- 800 E 20TH ST, #300
CHEYENNE, WY 82001 - Phone
- (307) 637-7700
Quick Facts
- NPI
- 1083741128
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 3
- Years in Practice
- 35
- Publications
- 20
Are you this provider?
Claim Your Profile